148 related articles for article (PubMed ID: 8002527)
21. Neurotropic effects of the optical isomers of the selective adenosine cyclic 3',5'-monophosphate phosphodiesterase inhibitor rolipram in rats in-vivo.
Wachtel H
J Pharm Pharmacol; 1983 Jul; 35(7):440-4. PubMed ID: 6136585
[TBL] [Abstract][Full Text] [Related]
22. Microvascular permeability and number of tight junctions are modulated by cAMP.
Adamson RH; Liu B; Fry GN; Rubin LL; Curry FE
Am J Physiol; 1998 Jun; 274(6):H1885-94. PubMed ID: 9841516
[TBL] [Abstract][Full Text] [Related]
23. Role of calmodulin and myosin light-chain kinase in lung ischemia-reperfusion injury.
Khimenko PL; Moore TM; Wilson PS; Taylor AE
Am J Physiol; 1996 Jul; 271(1 Pt 1):L121-5. PubMed ID: 8760141
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of granulocyte cAMP-phosphodiesterase by rolipram in vivo is not sufficient to protect the canine myocardium from reperfusion injury.
Simpson PJ; Schelm JA; Smallwood JK; Clay MP; Lindstrom TD
J Cardiovasc Pharmacol; 1992 Jun; 19(6):987-95. PubMed ID: 1376823
[TBL] [Abstract][Full Text] [Related]
25. Reduced ischemia-reperfusion injury with isoproterenol in non-heart-beating donor lungs.
Jones DR; Hoffmann SC; Sellars M; Egan TM
J Surg Res; 1997 May; 69(2):385-92. PubMed ID: 9224412
[TBL] [Abstract][Full Text] [Related]
26. Isoflurane-sevoflurane adminstration before ischemia attenuates ischemia-reperfusion-induced injury in isolated rat lungs.
Liu R; Ishibe Y; Ueda M
Anesthesiology; 2000 Mar; 92(3):833-40. PubMed ID: 10719962
[TBL] [Abstract][Full Text] [Related]
27. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
28. Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in rats.
Sasaki H; Hashimoto K; Maeda Y; Inada T; Kitao Y; Fukui S; Iyo M
Life Sci; 1995; 56(25):PL443-7. PubMed ID: 7791505
[TBL] [Abstract][Full Text] [Related]
29. Interferon-gamma and lipopolysaccharide reduce cAMP responses in cultured glial cells: reversal by a type IV phosphodiesterase inhibitor.
Patrizio M; Costa T; Levi G
Glia; 1995 Jun; 14(2):94-100. PubMed ID: 7558245
[TBL] [Abstract][Full Text] [Related]
30. Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model.
Hamamoto M; Suga M; Nakatani T; Takahashi Y; Sato Y; Inamori S; Yagihara T; Kitamura S
Eur J Cardiothorac Surg; 2004 May; 25(5):833-8. PubMed ID: 15082290
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic intervention in a rat model of ARDS: IV. Phosphodiesterase IV inhibition.
Turner CR; Esser KM; Wheeldon EB
Circ Shock; 1993 Mar; 39(3):237-45. PubMed ID: 8384094
[TBL] [Abstract][Full Text] [Related]
32. Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme.
Silva PM; Alves AC; Serra MF; Pires AL; Silva JP; Barreto EO; Cordeiro RS; Jose PJ; Teixeira MM; Lagente V; Martins MA
Br J Pharmacol; 2001 Sep; 134(2):283-94. PubMed ID: 11564646
[TBL] [Abstract][Full Text] [Related]
33. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
[TBL] [Abstract][Full Text] [Related]
34. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.
Blease K; Burke-Gaffney A; Hellewell PG
Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364
[TBL] [Abstract][Full Text] [Related]
35. Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitors.
Wachtel H
Psychopharmacology (Berl); 1982; 77(4):309-16. PubMed ID: 6182575
[TBL] [Abstract][Full Text] [Related]
36. Adenosine A2 receptors reverse ischemia-reperfusion lung injury independent of beta-receptors.
Khimenko PL; Moore TM; Hill LW; Wilson PS; Coleman S; Rizzo A; Taylor AE
J Appl Physiol (1985); 1995 Mar; 78(3):990-6. PubMed ID: 7775345
[TBL] [Abstract][Full Text] [Related]
37. Age-dependent changes in second messenger and rolipram receptor systems in the gerbil brain.
Araki T; Kato H; Kanai Y; Kogure K
J Neural Transm Gen Sect; 1994; 97(2):135-47. PubMed ID: 7873123
[TBL] [Abstract][Full Text] [Related]
38. Alpha 2-adrenoceptor mediated inhibition of forskolin-stimulated cyclic AMP accumulation in isolated porcine palmar lateral veins.
Wright IK; Kendall DA; Wilson VG
Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):113-20. PubMed ID: 7477432
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
Seldon PM; Barnes PJ; Giembycz MA
Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
[TBL] [Abstract][Full Text] [Related]
40. Antidepressant-like effects of rolipram and other inhibitors of cyclic adenosine monophosphate phosphodiesterase on behavior maintained by differential reinforcement of low response rate.
O'Donnell JM
J Pharmacol Exp Ther; 1993 Mar; 264(3):1168-78. PubMed ID: 8383740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
